Latest Updates

Cipla launches remdesivir under brand name CIPREMI

Read more

Maha govt plans to procure 10000 vials of remdesivir from Cipla

Read more

Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment

Read more

Unichem, Lupin voluntarily recall hypertension medicines in the US

Read more

Cipla, Hetero get DCGI nod to manufacture remdesivir

Read more

India: A global nutraceutical hub in the making

Read more

US FDA declines approval again for Nabriva’s antibiotic for UTI

Read more

Every innovation has to benefit mankind at large

Read more

Novartis stops HCQ trial against COVID-19 citing participant shortfall

Read more

Acute myeloid leukaemia market to reach $5.1 billion by 2029: GlobalData

Read more